Top Three Challenges Identified for Pharmacists in 2018
TUESDAY, Jan. 30, 2018 -- The top pharmacy challenges for 2018 are drug affordability, nonadherence, and pharmacist compensation, according to a report published online Jan. 7 in Managed Healthcare Executive.
Affordability has increasingly gained attention with the introduction of high-cost specialty pharmacy, which is replacing drugs off patent or filling voids in new drug classes. Prescription drugs need to be affordable, but pharmacies and insurance companies also need to be able to stay in business. Some innovative solutions have been developed to combat high costs, but there is little control over drug inflation. Solutions to affordability include assessing drug utilization and examining whether there are alternatives.
Drug affordability in an important contributor to drug nonadherence. Pharmacists have some responsibility for nonadherence; they should help reconcile patients' regimens to ensure drugs are taken correctly. The final major challenge is appropriate reimbursement for pharmacists, with pharmacists not being compensated for services beyond drug dispensing, despite them providing cognitive services, including medication management, patient education and counseling, promoting adherence, and giving wellness and prevention screenings. Pharmacists practicing in outpatient hospital or physician office settings can bill for special services; however, under Medicare, pharmacists are not currently recognized as providers and can't bill Medicare for services under the Part B benefit.
"Until pharmacists receive provider status, plans will not compensate them even though their functions have grown," Kelly Ann Barnes, vice president for PharmacyChecker.com, said, according to the report.
© 2020 HealthDay. All rights reserved.
Posted: January 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.